Thus, the drop of the activated αIIbβ3 complex on platelets of non-surviving COVID-19 patients, observed in the current study, may be attributed to a generally declining amount of total ITGA2B in their platelets due to hyper-activation. This evidence concerns the gene ITGA2B and COVID-19.